首页> 美国卫生研究院文献>Scientific Reports >Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease
【2h】

Arterial tissue transcriptional profiles associate with tissue remodeling and cardiovascular phenotype in children with end-stage kidney disease

机译:终末期肾脏疾病患儿的动脉组织转录谱与组织重塑和心血管表型有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic kidney disease (CKD) greatly increases the risk for cardiovascular disease (CVD). However, molecular mechanisms underlying CKD-induced arterial remodeling are largely unknown. We performed a systematic analysis of arterial biopsies from children with stage 5 predialysis CKD participating in the Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4 C) study. For comparison, we studied biopsies from children without CKD, coronary bypass vessels from adults with atherosclerotic coronary heart disease without CKD and aortic sections of subtotally nephrectomized rats. In pediatric CKD patients, gene expression was correlated to the cardiovascular phenotype assessed by surrogate end-points. The arterial calcium content correlated with the intima-media thickness (IMT) of biopsied vessels from pediatric CKD patients, was markedly increased compared to biopsies from children without CKD and comparable to adult coronary bypass patients. Significant transcriptional changes included ECM components, pro-calcifying factors, and physiological calcification inhibitors; most were highly accordant with changes observed in adults with atherosclerosis and in uremic rats. Individual gene expression levels were significantly associated with the left ventricular mass index and carotid intima media thickness. Thus, inflammatory processes (TNF, IL-10), calcification inhibitors (CA2), the Wnt-pathway (FGF-2) and foremost, ECM components (HMGA1, VNN1, VCAN), impact pathobiological responses in arteries from children with CKD.
机译:慢性肾脏疾病(CKD)大大增加了患心血管疾病(CVD)的风险。但是,CKD诱导的动脉重塑的分子机制尚不清楚。我们对参与慢性肾脏病(4 C)患儿心血管合并症的5期透析前CKD患儿的动脉活检进行了系统分析。为了进行比较,我们研究了没有CKD的儿童的活检,没有CKD的患有动脉粥样硬化性冠心病的成年人的冠状动脉旁路血管以及全肾切除的大鼠的主动脉切片。在小儿CKD患者中,基因表达与通过替代终点评估的心血管表型相关。与没有CKD的儿童活检相比,与成人冠状动脉搭桥术患者相比,与儿童CKD活检相比,动脉钙含量与活检血管的内膜中层厚度(IMT)相关。重大的转录变化包括ECM成分,促钙化因子和生理性钙化抑制剂。大多数与成年动脉粥样硬化和尿毒症大鼠的变化高度一致。个体基因表达水平与左心室质量指数和颈动脉内膜中层厚度显着相关。因此,炎症过程(TNF,IL-10),钙化抑制剂(CA2),Wnt途径(FGF-2)以及最重要的ECM成分(HMGA1,VNN1,VCAN)影响患有CKD的患儿动脉的病理生物学反应。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号